In simple terms, PharmGen Science, Inc. has 17.961 M shares that people are buying and selling right now. When we look at how much money they make before expenses, they keep 0.580% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is 0.585%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of 0.030%. This tells us they're good at keeping money after all costs.
Return on Investments
The company's asset efficiency, represented by a robust 0.014% return, is a testament to PharmGen Science, Inc.'s adeptness in optimizing resource deployment. PharmGen Science, Inc.'s utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.022%. Furthermore, the proficiency of PharmGen Science, Inc. in capital utilization is underscored by a remarkable 0.348% return on capital employed.
Stock Prices
PharmGen Science, Inc.'s stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $6230, while its low point bottomed out at $6000. This variance in figures offers investors a lucid insight into the roller-coaster ride that is PharmGen Science, Inc.'s stock market.
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
